Alkem Laboratories Limited (BOM:539523)

Alkem Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 5, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	591,428	590,890	406,055	432,909	331,171	278,090
Market Cap Growth	8.29%	45.52%	-6.20%	30.72%	19.09%	32.84%
Enterprise Value	587,491	573,042	400,038	427,311	330,764	281,854
Last Close Price	4949.80	4897.18	3338.13	3506.05	2660.35	2213.28
PE Ratio	27.47	32.91	41.26	26.31	20.89	24.67
PS Ratio	4.64	4.67	3.50	4.07	3.74	3.33
PB Ratio	4.97	5.52	4.30	4.89	4.38	4.41
P/TBV Ratio	5.40	6.01	4.75	5.30	4.80	4.91
P/FCF Ratio	-	34.99	28.01	56.07	30.95	125.27
P/OCF Ratio	-	30.33	24.13	38.97	26.18	47.53
EV/Sales Ratio	4.61	4.52	3.45	4.02	3.73	3.38
EV/EBITDA Ratio	23.55	25.73	25.17	21.24	17.27	18.97
EV/EBIT Ratio	26.51	29.13	30.32	24.51	19.76	22.26
EV/FCF Ratio	-	33.93	27.60	55.34	30.91	126.97
Debt / Equity Ratio	0.12	0.13	0.15	0.30	0.24	0.27
Debt / EBITDA Ratio	0.59	0.63	0.86	1.31	0.92	1.14
Debt / FCF Ratio	-	0.84	0.96	3.46	1.68	7.76
Asset Turnover	-	0.86	0.83	0.83	0.83	0.92
Inventory Turnover	-	1.92	1.79	1.61	1.73	2.06
Quick Ratio	-	1.68	0.94	0.70	1.01	0.72
Current Ratio	-	2.61	2.36	1.76	1.92	1.70
Return on Equity (ROE)	-	17.98%	11.01%	20.48%	23.33%	19.35%
Return on Assets (ROA)	-	8.38%	5.93%	8.52%	9.75%	8.72%
Return on Capital (ROIC)	11.06%	10.71%	7.38%	10.44%	12.04%	10.88%
Return on Capital Employed (ROCE)	-	17.00%	13.10%	18.80%	21.10%	18.90%
Earnings Yield	3.64%	3.04%	2.42%	3.80%	4.79%	4.05%
FCF Yield	-	2.86%	3.57%	1.78%	3.23%	0.80%
Dividend Yield	0.84%	0.82%	0.75%	0.97%	1.13%	1.13%
Payout Ratio	-	29.96%	23.08%	25.43%	21.12%	31.82%
Buyback Yield / Dilution	0.01%	-	-	-	-	-
Total Shareholder Return	0.84%	0.82%	0.75%	0.97%	1.13%	1.13%

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.